SWAV - Trinh Phung At Shockwave Medical Capitalizes: Options Exercised Resulting In $6.48M | Benzinga
A substantial insider activity was disclosed on May 21, as Phung, VP at Shockwave Medical (NASDAQ:SWAV), reported the exercise of a large sell of company stock options.
What Happened: The latest Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission uncovered Phung, VP at Shockwave Medical, exercising stock options for 19,763 shares of SWAV. The total transaction was valued at $6,482,222.
Currently, Shockwave Medical shares are trading up 1.37%, priced at $334.16 during Wednesday's morning. This values Phung's 19,763 shares at $6,482,222.
About Shockwave Medical
Shockwave Medical Inc is a medical device company focused on developing and commercializing novel technologies that transform the care of patients with cardiovascular disease. It establishes a new standard of care for the treatment of calcified cardiovascular disease ("atherosclerosis") through differentiated and proprietary local delivery of sonic pressure waves, which refer to as intravascular lithotripsy ("IVL"). Its IVL technology is a minimally invasive, easy-to-use, and safe way to improve outcomes for patients with calcified cardiovascular disease also IVL catheters enables delivery of IVL therapy to diseased vasculature throughout the body for calcium modification.
Understanding the Numbers: Shockwave Medical's Finances
Revenue Growth: Shockwave Medical's remarkable performance in 3 months is evident. As of 31 March, ...